InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.140
+0.070 (6.54%)
At close: Apr 14, 2026, 4:00 PM EDT
1.130
-0.010 (-0.88%)
Pre-market: Apr 15, 2026, 7:08 AM EDT
InflaRx Market Cap
InflaRx has a market cap or net worth of $82.41 million as of April 15, 2026. Its market cap has increased by 11.07% in one year.
Market Cap
82.41M
Enterprise Value
28.92M
1-Year Change
11.07%
Ranking
Category
Stock Price
$1.14
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $350.90M to $82.41M, a decrease of -76.51%. That is a compound annual growth rate of -15.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 77.40M | 13.16% |
| Dec 31, 2025 | 68.40M | -52.96% |
| Dec 31, 2024 | 145.40M | 51.46% |
| Dec 29, 2023 | 96.00M | -29.93% |
| Dec 30, 2022 | 137.00M | -34.85% |
| Dec 31, 2021 | 210.30M | 60.17% |
| Dec 31, 2020 | 131.30M | 27.72% |
| Dec 31, 2019 | 102.80M | -88.13% |
| Dec 31, 2018 | 866.00M | 76.55% |
| Dec 29, 2017 | 490.50M | 39.78% |
| Nov 8, 2017 | 350.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PolyPid | 84.35M |
| Rani Therapeutics Holdings | 83.50M |
| MAIA Biotechnology | 83.12M |
| OKYO Pharma | 82.92M |
| NRx Pharmaceuticals | 82.59M |
| Seres Therapeutics | 82.54M |
| aTyr Pharma | 82.45M |
| Fractyl Health | 80.70M |